{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
INN:tivanisiran [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:avacincaptad pegol [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT02147197: Phase 3 Interventional Completed Leiomyoma
(2014)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT01191372: Phase 1 Interventional Terminated Hemophilia
(2010)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
JAN:FITUSIRAN SODIUM [JAN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:egaptivon pegol [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID